TickrTrends PHAT fair value analysis

BDR Pharmaceuticals Sues FDA Over Voquezna Application, Impacting PHAT Stock

gurufocus.com · 2026-10-23

On October 23, 2026, Phathom Pharmaceuticals Inc (PHAT) faces legal uncertainty as BDR Pharmaceuticals initiates a lawsuit challenging the FDA's refusal to acce

Read the full story at gurufocus.com →

Is PHAT undervalued? See TickrTrends' fair value analysis →